Table 1 Demographic and clinical characteristics between two groups in patients with COVID-19
Variables Early-stage group (n = 34) Progressive-stage group (n = 28) p value
Demographic
  Age, (years) 44.32 ± 13.53 50.82 ± 13.23 0.062
  Male 18 (52.9%) 16 (57.1%) 0.741 (χ)
Exposure history 0.494 (χ)
  Positive 27 (79.4%) 24 (85.7%)
  Negative 4 (11.8%) 1 (3.6%)
  Unknown 3 (8.8%) 3 (10.7%)
Symptoms
  Fever (°C) 37.70 ± 0.73 37.66 ± 0.94 0.854
  < 37.4 °C 8 (23.5%) 11 (39.3%) 0.064 (χ)
  37.4–38 °C 20 (58.8%) 9 (32.1%)
  38.1–39 °C 4 (11.8%) 6 (21.4%)
  39.1–41 °C 2 (5.9%) 2 (7.1%)
Laboratory tests
  CRP (mg/L) 15.98 (1.78–55.98) 35.62 (5.63–63.04) 0.329
  White blood cell count (× 109/L) 5.78 ± 1.93 6.24 ± 3.55 0.518
  Neutrophil count (× 109/L) 0.71 ± 0.13 0.74 ± 0.11 0.343
  Lymphocyte count (× 109/L) 1.04 ± 0.49 0.97 ± 0.46 0.541
  Platelet count (× 109/L) 180.79 ± 66.83 190.18 ± 73.91 0.602
  Hemoglobin (g/dL) 13.72 ± 1.79 13.69 ± 1.80 0.956
  Procalcitonin (ng/mL) 0.05 (0.04–0.07) 0.07 (0.04–0.11) 0.234
COVID-19, coronavirus disease 2019; CRP, C-reactive protein